Multi-omics assessment of individuals infected with COVID-19 (Michael Snyder)

The Snyder group will collect biological samples from individuals ill with COVID-19 and those most at risk for the disease, observing and assessing levels of certain molecules involved in several biological pathways, including metabolism and immune function. The team will use this information to create “omics” profiles to look for potential molecular signatures of COVID-19 infection, as well as signs that an individual might have a strong adverse reaction to the virus. Stanford Office of Technology Licensing 650-723-0651

Related Blog

Smart, interactive desk

Get ready to take your space management game to the next level with the University of Glasgow’s innovative project! By combining the

Mechanical Hamstring™

University of Delaware Technology Overview This device was created to allow athletes who suffer a hamstring strain to return to the field

Join Our Newsletter

                                                   Receive Innovation Updates, New Listing Highlights And More